Skip to main content

Advertisement

SpringerLink
Log in

Soft Tissue Infections Caused by Marine Bacterial Pathogens: Epidemiology, Diagnosis, and Management

  • Published:
Current Infectious Disease Reports Aims and scope Submit manuscript

Abstract

Skin and soft tissue infections (SSTIs) are one of the most common infection syndromes and may be caused by a large number of microorganisms. Some principles of aquatic injuries are different than those of land-based trauma. Wounds sustained in marine environment are exposed to a milieu of bacteria rarely encountered in different settings. These include Vibrio spp., Aeromonas spp., Shewanella spp., Erysipelothrix rhusiopathiae, Mycobacterium marinum, Streptococcus iniae, and other microbes. Failure to recognize and treat these uncommon pathogens in a timely manner may result in significant morbidity or death. These infections are frequently contracted as a result of recreational swimming, fishing injuries, or seafood handling. The spectrum of manifestations is wide, varying from cases of mild cellulitis, to severe life-threatening necrotizing fasciitis requiring radical surgery, to sepsis and death. This review will focus on the epidemiology, clinical manifestations, and treatment of SSTIs caused by the most important marine pathogens.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. • Dryden MS. Complicated skin and soft tissue infection. J Antimicrob Chemother. 2010;65(Suppl 3):iii35–44. This is a recent and complete overview of complicated skin and soft tissue infection, including those caused by less common pathogens.

    Article  PubMed  CAS  Google Scholar 

  2. Di Nubile MJ, Lipsky BA. Complicated infections of the skin and skin structures: when the infection is more than skin deep. J Antimicrob Chemother. 2004;53 Suppl 2:ii37–50.

    Article  Google Scholar 

  3. Stevens DL, Bisno AL, Chambers H, et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis. 2005;41:1373–406.

    Article  PubMed  Google Scholar 

  4. Eron LJ, Lipsky BA, Low DE, et al. Managing skin and soft tissue infections: expert panel recommendations on key decision points. J Antimicrob Chemother. 2003;52 Suppl 1:i3–i17.

    Article  PubMed  CAS  Google Scholar 

  5. Pomeroy LR. The microbial food web. Oceanus. 1992;35(3):28–35.

    Google Scholar 

  6. Haddad Jr V, Lupi O, Lonza JP, Tyring SK. Tropical dermatology: marine and aquatic dermatology. J Am Acad Dermatol. 2009;61:733–50.

    Article  PubMed  Google Scholar 

  7. Kueh CSW, Kutarski P, Brunton M. Contaminated marine wounds—the risk of acquiring acute bacterial infection from marine recreational beaches. J Appl Bacteriol. 1992;73:412–20.

    PubMed  CAS  Google Scholar 

  8. Auerbach PS, Yajko DM, Nassos PS, et al. Bacteriology of the marine environment: implications for clinical therapy. Ann Emerg Med. 1987;16:643–9.

    Article  PubMed  CAS  Google Scholar 

  9. Noonburg GE. Management of extremity trauma and related infections occurring in the aquatic environment. J Am Acad Orthop Surg. 2005;13:243–53.

    PubMed  Google Scholar 

  10. Reed KC, Crowel MC. Skin and soft tissue infections after injury in ocean: culture methods and antibiotic therapy for marine bacteria. Mil Med. 1999;164:198–201.

    PubMed  CAS  Google Scholar 

  11. Buck JD, Spotte S, Gadbaw JJ, Jr. Bacteriology of teeth from great white shark: potential medical implications for shark bite victims. J Clin Microbiol. 1984;849–51.

  12. Hlady WG, Klontz K. The epidemiology of Vibrio infections in Florida, 1981–1993. J Infect Dis. 1996;173:1176–83.

    Article  PubMed  CAS  Google Scholar 

  13. Blake P, Weaver R, Hollis D. Diseases of humans (other than cholera) caused by vibrio. Annu Rev Microbiol. 1980;34:341–67.

    Article  PubMed  CAS  Google Scholar 

  14. Feldhusen F. The role of seafood in bacterial foodbourne diseases. Microbes Infect. 2000;2:1651–60.

    Article  PubMed  CAS  Google Scholar 

  15. • Jones MK, Oliver JD. Vibrio vulnificus: disease and pathogenesis. Infect Immun. 2009;77:1723–33. This minireview includes an in-depth discussion on the physiologic characteristics of Vibrio vulnificus.

    Article  PubMed  CAS  Google Scholar 

  16. Oliver JD. Wound infections caused by Vibrio vulnificus and other marine bacteria. Epidemiol Infect. 2005;133:383–91.

    Article  PubMed  CAS  Google Scholar 

  17. • Dechet AM, Yu PA, Koram N, Painter J. Nonfoodborne Vibrio infections: An important cause of morbidity and mortality in the United States, 1997–2006. Clin Infect Dis. 2008;46:970–6. This study represents the largest series of nonfoodborne Vibrio infections (including soft tissue infections) reported.

    Article  PubMed  Google Scholar 

  18. Bisharat N, Agmon V, Finkelstein R, et al. Clinical, epidemiological, and microbiological features of Vibrio vulnificus biogroup 3 causing outbreaks of wound infection and bacteraemia in Israel. Israel Vibrio Study Group. Lancet. 1999;354:1421–4.

    Article  PubMed  CAS  Google Scholar 

  19. Park K-H, Jung S-I, Jung Y-S, et al. Marine bacteria as a leading cause of necrotizing fasciitis in coastal areas of South Korea. Am J Trop Med Hyg. 2009;80:646–50.

    PubMed  Google Scholar 

  20. Zaidenstein R, Sadik C, Lerner L, et al. Clinical characteristics and molecular subtyping of Vibrio vulnificus illnesses, Israel. Em Infect Dis. 2008;14:1875–82.

    Article  CAS  Google Scholar 

  21. Koenig KL, Mueller J, Rose T. Vibrio vulnificus: hazard on half shell. West J Med. 1991;155:400–3.

    PubMed  CAS  Google Scholar 

  22. Amaro C, Biosca EG. Vibrio vulnificus biotype 2, pathogenic for eels, is also an opportunistic pathogen for humans. Appl Environ Microbiol. 1996;62:1454–7.

    PubMed  CAS  Google Scholar 

  23. Tison DL, Nishibuchi M, Greenwood JD, Seidler RJ. Vibrio vulnificus biogroup 2: new biogroup pathogenic for eels. Appl Environ Microbiol. 1982;44:640–6.

    PubMed  CAS  Google Scholar 

  24. Chuang Y-C, Yuan C-Y, Liu C-Y, et al. Vibrio vulnificus infection in Taiwan: Report of 28 cases and review of clinical manifestations and treatment. Clin Infect Dis. 1992;15:271–6.

    Article  PubMed  CAS  Google Scholar 

  25. Howard RJ, Bennett NT. Infections caused by halophilic marine Vibrio bacteria. Ann Surg. 1993;217:525–31.

    Article  PubMed  CAS  Google Scholar 

  26. Shapiro RL, Altekruse S, Hutwagner L, the Vibrio Working Group, et al. The role of gulf coast oysters harvested in warmer months in Vibrio vulnificus infections in the United States, 1988–1996. J Infect Dis. 1998;178:752–9.

    Article  PubMed  CAS  Google Scholar 

  27. Kuo Y-L, Shieh S-J, Chiu H-Y, Lee J-W. Necrotizing fasciitis caused by Vibrio vulnificus: epidemiology, clinical findings, treatment and prevention. Eur J Clin Microbiol Infect Dis. 2007;26:785–92.

    Article  PubMed  Google Scholar 

  28. Hsueh P-R, Lin C-Y, Tang H-J, et al. Vibrio vulnificus in Taiwan. Emerg Infect Dis. 2004;10:1363–8.

    PubMed  Google Scholar 

  29. Forbes BA, Sahm DF, Weissfeld AS. Vibrio, Aeromonas, Pleisiomonas, Shigelloides, and Chromobacterium violaceum. In: Forbes BA, Sahm DF, Weissfeld AS, editors. Bailey & Scott’s diagnostic microbiology. 11th ed. St. Louis: Mosby, Inc.; 2002. p. 423–33.

    Google Scholar 

  30. Muldrew KL, Simpson JF, Stratton CW, Tang YW. Molecular diagnosis of necrotizing fasciitis by 16S rRNA gene sequencing and superantigen gene detection. J Mol Diagn. 2005;7:641–5.

    Article  PubMed  CAS  Google Scholar 

  31. Lee C-H, Wang C-C, Yue C-T et al. Necrotizing fasciitis caused by Vibrio vulnificus in a man with cirrhosis. Lancet Infect Dis. 2008;399.

  32. Chuang Y-C, Liu J-W, Ko W-C, et al. In vitro synergism between cefotaxime and minocycline against Vibrio vulnificus. Antimicrob Agents Chemother. 1997;41:2214–7.

    PubMed  CAS  Google Scholar 

  33. Tang H-J, Chang M-C, Ko W-C, et al. In vitro and in vivo activities of newer fluoroquinolones against Vibrio vulnificus. Antimicrob Agents Chemother. 2002;46:3580–4.

    Article  PubMed  CAS  Google Scholar 

  34. Chuang Y-C, Ko W-C, Wang S-T, et al. Minocycline and cefotaxime in the treatment of experimental murine Vibrio vulnificus infection. Antimicrob Agents Chemother. 1998;42:1319–22.

    PubMed  CAS  Google Scholar 

  35. The Sandford guide to antimicrobial therapy. In: Gilbert DN, Moellering RC, Eliopoulos GM, Chambers HF, Saag MS, editors. 40th ed; 2010. p. 51.

  36. Jones BL, Wilcox MH. Aeromonas infections and their treatment. J Clin Microbiol. 1995;35:453–61.

    CAS  Google Scholar 

  37. Tsai Y-H, Hsu RW-W, Huang T-J, et al. Necrotizing soft-tissue infections and sepsis caused by Vibrio vulnificus compared with those caused by Aeromonas species. J Bone Joint Surg Am. 2007;89:631–6.

    Article  PubMed  Google Scholar 

  38. Gold WL, Salit IE. Aeromonas hydrophila infections of skin and soft tissue: report of 11 cases and review. Clin Infect Dis. 1993;16:69–74.

    Article  PubMed  CAS  Google Scholar 

  39. Janda JM. Recent advances in the study of the taxonomy, pathogenicity and infectious syndromes associated with the genus aeromonas. Clin Microbiol Rev. 1991;4:397–410.

    PubMed  CAS  Google Scholar 

  40. Ghenghesh KS, Ahmed SF, El-Khalek RA, et al. Aeromonas-associated infections in developing countries. J Infect Developing Countries. 2008;2:81–98.

    Article  Google Scholar 

  41. Steinberg JP, Burd EM. Other gram-negative and gram-variable bacilli. Aeromonas species. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. 7th ed. Elsevier; 2010. pp. 3017–9.

  42. •• Janda JM, Abbott SL. The genus Aeromonas: taxonomy pathogenesis and infection. Clin Microbiol Rev. 2010;23:35–73. This is the more recent and thorough review on Aeromonas infection.

    Article  PubMed  CAS  Google Scholar 

  43. Lamy B, Kodjo A, Laurent F. Prospective nationwide study of Aeromonas infections in France. J Clin Microbiol. 2009;47:1234–7.

    Article  PubMed  CAS  Google Scholar 

  44. Davis II WA, Kane JG, Garagusi VF. Human Aeromonas infections. A review of the literature and a case report of endocarditis. Medicine. 1978;57:267–77.

    Article  PubMed  Google Scholar 

  45. Harris RL, Fainstein V, Elting L, et al. Bacteremia caused by Aeromonas species in hospitalized cancer patients. Rev Infect Dis. 1985;7:314–20.

    Article  PubMed  CAS  Google Scholar 

  46. Martino R, Santamaria A, Pericas R, et al. Acute rhabdomyolysis and myonecrosis complicating aeromonas bacteremia in neutropenic patients with hematologic malignancies: report of two cases. Haematologica. 1997;82:692–4.

    PubMed  CAS  Google Scholar 

  47. Hanson PG, Standridge J, Jarret F, Maki DG. Freshwater wound infection due to aeromonas hydrophila. JAMA. 1977;238:1053–4.

    Article  PubMed  CAS  Google Scholar 

  48. Hiransuthikul N, Tantisirivat W, Lertutsahakul K, et al. Skin and soft-tissue infections among Tsunami survivors in southern Thailand. Clin Infect Dis. 2005;41:e93–6.

    Article  PubMed  Google Scholar 

  49. Ribeiro NFF, Heath CH, Kierath J, et al. Burn wounds infected by contaminated water: case reports, review of the literature and recommendations for treatment. Burns. 2010;36:9–22.

    Article  PubMed  Google Scholar 

  50. Tena D, Gonzales-Praetorius A, Gimeno C, et al. Rapidly progressive myonecrosis by Aeromonas veronii biotype sobria. An Med Interna. 2006;23:540–2.

    PubMed  CAS  Google Scholar 

  51. Bauters TG, Buyla FM, Verschraegen G, et al. Infection risk related to the use of medicinal leeches. Pharm World Sci. 2007;29(3):122–5.

    Article  PubMed  Google Scholar 

  52. Sartor C, Limouzin-Perotti F, Legre R, et al. Nosocomial infections with Aeromonas hydrophila from leeches. Clin Infect Dis. 2002;35:e1–5.

    Article  PubMed  Google Scholar 

  53. Liu BM, Chandchien CS, Chen CH, et al. Fatal aeromonas hydrophila infection of soft tissue after endoscopic injection sclerotherapy for gastric variceal bleeding. Chang Gung Med J. 2004;27(10):766–9.

    PubMed  Google Scholar 

  54. Derby HA, Hammer HA. Bacteriology of butter. IV. Bacteriological studies on surface taint butter. Iowa Agric Exp Station Res Bull. 1931;145:389–416.

    Google Scholar 

  55. Long HF, Hammer BW. Classification of organisms important in dairy products. III. Pseudomonas putrefaciens. Iowa Agric Exp Station Res Bull. 1941;285:176–95.

    Google Scholar 

  56. MacDonell MT, Colwell RR. Phylogeny of the Vibrionaceae, and recommendation for two new genera, Listonella and Shewanella. Syst Appl Microbiol. 1985;6:171–82.

    CAS  Google Scholar 

  57. Holt HM, Gahrn-Hansen B, Bruun B. Shewanella algae and Shewanella putrefaciens: clinical and microbiological characteristics. Clin Microbiol Infect. 2005;11:347–52.

    Article  PubMed  CAS  Google Scholar 

  58. Kueh HC, Kutarski P, Brunton M. Contaminated marine wounds—the risk of acquiring acute bacterial infection from marine recreational beaches. J Appl Bacteriol. 1992;73:412–20.

    PubMed  CAS  Google Scholar 

  59. Oh HS, Kum KA, Kim EC, et al. Outbreak of Shewanella algae and Shewanella putrefaciens infections caused by a shared measuring cup in a general surgery unit in Korea. Infect Control Hosp Epidemiol. 2008;29:742–8.

    Article  PubMed  Google Scholar 

  60. Tsai MS, You HL, Tang YF, Liu JW. Shewanella soft tissue infection: case report and literature review. Int J Infect Dis. 2008;12:e119–24.

    Article  PubMed  Google Scholar 

  61. Tsai TH, You HY. Nectotyzing fasciitis caused by shewanella putrefaciens in a uremic patient. J Microbiol Immunol Infect. 2006;39:516–8.

    PubMed  Google Scholar 

  62. Sharma KK, Kalawat U. Emerging infections: Shewanella—a series of five cases. J Lab Physicians. 2010;2:61–5.

    Article  PubMed  CAS  Google Scholar 

  63. Chen Y, Liu Y, Yen M, et al. Skin and soft-tissue manifestations of Shewanella putrfaciens infection. Clin Infect Dis. 1997;25:225–9.

    Article  PubMed  CAS  Google Scholar 

  64. Pagani L, Lang A, Vedovelli C, et al. Soft tissue infecctions and bacteremia caused by Shewanella putrefaciens. J Clin Microbiol. 2003;41(5):2240–1.

    Article  PubMed  Google Scholar 

  65. Botelho-Nevers E, Gouriet F, Rovery C, et al. First case of osteomyelitis due to Shewanella algae. J Clin Microbiol. 2005;43(10):5388–90.

    Article  PubMed  CAS  Google Scholar 

  66. Ternavasio-de-la-Vega HG, Angel-Moreno A, Hernández-Cabrera M, et al. Skin and soft tissue infections (patera foot) in immigrants, Spain. Emerg Infect Dis. 2009;15(4):598–600.

    Article  PubMed  Google Scholar 

  67. Bring IJ, van Staten A, van Rensburg AJ. Shewanella (pseudomonas) putrefaciens bacteremia. Clin Infect Dis. 1995;20:1327–32.

    Article  Google Scholar 

  68. Appelbaum PC, Bowen AJ. Opportunistic infection of chronic skin ulcers with Pseudomonas putrefaciens. Br J Dermatol. 1978;98:229–31.

    Article  PubMed  CAS  Google Scholar 

  69. Domínguez H, Vogel BF, Gram L, et al. Shewanella alga bacteremia in two patients with lower leg ulcers. Clin Infect Dis. 1996;22:1036–9.

    Article  PubMed  Google Scholar 

  70. Kim JH, Cooper RA, Welty WK, et al. Pseudomonas putrefaciens bacteremia. Rev Infect Dis. 1989;11:97–104.

    Article  PubMed  CAS  Google Scholar 

  71. Pope TL, Teague WG, Kossack R, et al. Pseudomonas sacroiliac osteomyelitis: diagnosis by gallium citrate Ga 67 scan. Am J Dis Child. 1982;136(7):649–50.

    PubMed  CAS  Google Scholar 

  72. Levy PY, Tessier JL. Arthritis due to Shewanella purtrefaciens. Clin Infect Dis. 1998;26:536.

    Article  PubMed  Google Scholar 

  73. Laudat P, Audurier A, Loulergue F, et al. Pseudomonas putrefaciens meningitis. J Infect. 1983;7(3):281–3.

    Article  PubMed  CAS  Google Scholar 

  74. 'Süzük S, Yetener V, Ergüngör F, Balaban N. Cerebellar abscess caused by Shewanella putrefaciens. Scand J Infect Dis. 2004;36(8):621–2.

    Article  PubMed  Google Scholar 

  75. Dhawan B, Chaudhry R, Mishra BM, Agarwal R. Isolation of Shwanella purtrefaciens from a rheumatic heart disease patient with infective endocarditis. J Clin Microbiol. 1998;36:2394.

    PubMed  CAS  Google Scholar 

  76. Butt AA, Figueroa J, Martin DH. Ocular infection caused by three unusual marine organisms. Clin Infect Dis. 1997;24:740.

    Article  PubMed  CAS  Google Scholar 

  77. Kueh HC, Kutarski P, Brunton M. Contaminated marine wounds-the risk of acquiring acute bacterial infection from marine recreational beaches. J Appl Bacteriol. 1992;73:412–20.

    PubMed  CAS  Google Scholar 

  78. Roger SD, Chen SC, Lawrence S, Sorrell TC. Pseudomonas purtrefaciens bacteremia in a peritoneal dialysis patient. Nephrol Dial Transplant. 1991;6:73.

    PubMed  CAS  Google Scholar 

  79. Chen SC, Lawrence RH, Packham DR, Sorell TC. Cellulitis due to pseudomonas purtrefaciens: possible production of exotoxins. Rev Infect Dis. 1991;13(4):642–3.

    Article  PubMed  CAS  Google Scholar 

  80. Holt HM, Gahrn-Hansen B, Braun B. Shewanella species: infections in Denmark and phenotypic characterization. Clin Microbiol Infect. 2004;20 suppl 3:343–9.

    Google Scholar 

  81. Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175:367–416.

    Article  PubMed  CAS  Google Scholar 

  82. Piersimoni C, Scarparo C. Extrapulmonary infections associated with nontuberculous mycobacteria in immunocompetent persons. Emerg Infect Dis. 2009;15:1351–8.

    Article  PubMed  Google Scholar 

  83. Falkinham JO. Epidemiology of infection by nontuberculosis mycobacteria. Clin Microbiol Rev. 1996;9:177–215.

    PubMed  Google Scholar 

  84. Wagner D, Young LS. Nontuberculous mycobacterial infections: a clinical review. Infection. 2004;32:257–70.

    Article  PubMed  CAS  Google Scholar 

  85. Aubry A, Chosidow O, Caumes E, et al. Sixty-three cases of Mycobacterium marinum infection: clinical features, treatment, and antibiotic susceptibility of causative isolates. Arch Intern Med. 2002;162(15):1746–52.

    Article  PubMed  Google Scholar 

  86. Gluckman SJ. Mycobacterim marinum. Clin Dermatol. 1995;13(3):273–6.

    Article  PubMed  CAS  Google Scholar 

  87. Danko JR, Gilliland WR, Miller RS, Decker CF. Disseminated Mycobacterium marinum infection in a patient with rheumatoid arthritis receiving infliximab therapy. Scand J Infect Dis. 2009;41:252–5.

    Article  PubMed  Google Scholar 

  88. Imakado S, Kojima Y, Hiyoshi T, Morimoto S. Disseminated Mycobacterium marinum infection in a patient with diabetic nephropathy. Diabetes Res Clin Pract. 2009;83(2):e35–6.

    Article  PubMed  Google Scholar 

  89. Casal M, Casal MM, Spanish Group of Mycobacteriology. Multicenter study of incidence of Mycobacterium marinum in humans in Spain. Int J Tuberc Lung Dis. 2001;5:197–9.

    PubMed  CAS  Google Scholar 

  90. Liao CH, Lai CC, Ding LW, et al. Skin and soft tissue infection caused by non-tuberculous mycobacteria. Int J Tuberc Lung Dis. 2007;11(1):96–102.

    PubMed  CAS  Google Scholar 

  91. Chen HY, Chen CY, Huang CT, et al. Skin and soft-tissue infection caused by non-tuberculous mycobacteria in Taiwan, 1997–2008. Epidemiol Infect. 2011;139(1):121–9.

    Article  PubMed  Google Scholar 

  92. Agnew W, Barnes AC. Streptococcus iniae: An aquatic pathogen of global veterinary significance and a challenging candidate for reliable vaccination. Vet Microbiol. 2007;122:1–15.

    Article  PubMed  CAS  Google Scholar 

  93. Peir GB, Madin SH. Streptococcus iniae sp. nov., a betahemolytic streptococcus isolated from an Amazon freshwater dolphin, Inia geoffrensis. Int J Syst Bacteriol. 1976;26:545–53.

    Article  Google Scholar 

  94. Weinstein MR, Litt M, Kertesz DA, et al. Invasive infections due to a fish pathogen, Streptococcus iniae. S.iniae study group. N Engl J Med. 1997;337:589–94.

    Article  PubMed  CAS  Google Scholar 

  95. Hansen GR, Woodall J, Brown C, et al. Emerging zoonotic diseases. Panel summary from the International Conference on Emerging Infectious Diseases Conference, Atlanta, Georgia, 2000. Emerg Infect Dis. 2001;7:537.

    Article  PubMed  CAS  Google Scholar 

  96. Sun J-R, Yan J-C, Yeh C-Y, et al. Invasive infection with Streptococcus iniae in Taiwan. J Med Microbiol. 2007;56:1246–9.

    Article  PubMed  Google Scholar 

  97. Koh TH, Sng LH, Yuen SM, et al. Streptococcal cellulitis following preparation of fresh raw seafood. Zoonoses Public Health. 2009;56:206–8.

    Article  PubMed  CAS  Google Scholar 

  98. Lau SKP, Woo PCY, Tse H, et al. Invasive Streptococcus iniae infections outside North America. J Clin Microbiol. 2003;41:1004–9.

    Article  PubMed  Google Scholar 

  99. Facklam R, Elliott J, Shewmaker L, Reingold A. Identification and characterization of sporadic isolates of Streptococcus iniae isolated from humans. J Clin Microbiol. 2005;43:933–7.

    Article  PubMed  Google Scholar 

  100. Fuller JD, Bast DJ, Nizet V, et al. Streptococcus iniae virulence is associated with a distinct genetic profile. Infect Immun. 2001;69:1994–2000.

    Article  PubMed  CAS  Google Scholar 

  101. Reboli AC. Erysipelothrix rhusiopathiae. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. 7th ed. Elsevier; 2010. pp. 2733–5.

  102. Wood RL. Erysipelothrix infection. In: Hubbert WT, McCullough WF, Schnurrenberger PR, editors. Diseases transmitted from animals to man. 6th ed. Springfield: Thomas; 1975. p. 271–81.

    Google Scholar 

  103. • Tlougan BE, Podjasel JO, Adams BB. Aquatic sport dermatoses: part 3 on the water. Int J Dermatol. 2010;49:1111–20. This is one of a three-part comprehensive series on water-related dermatologic conditions seen in people participating in aquatic activities.

    Article  PubMed  Google Scholar 

  104. Nelson E. Five hundred cases of erysipeloid. Rocky Mtn Med J. 1955;52:40–2.

    CAS  Google Scholar 

  105. Collier DN. Cutaneous infections from coastal and marine bacteria. Dermatol Ther. 2002;15:1–9.

    Article  Google Scholar 

  106. Grieco MH, Sheldon C. Erysipelothrix rhusiopathiae. Ann N Y Acad Sci. 1970;174:523–32.

    Article  PubMed  CAS  Google Scholar 

  107. Hocqueloux L, Poisson DM, Sunder S, et al. Septic arthritis caused by Erysipelothrix rhusiopathiae in a prosthetic knee joint. J Clin Microbiol. 2010;48:333–5.

    Article  PubMed  Google Scholar 

  108. Brooke CJ, Riley TV. Erysipelothrix rhusiopathiae: bacteriology, epidemiology and clinical manifestations of an occupational pathogen. J Med Microbiol. 1999;48:789–99.

    Article  PubMed  CAS  Google Scholar 

  109. Fidalgo SG, Riley TV. Detection of Erypelothrix rhusiopatieae in clinical and environmental samples. Methods Mol Biol. 2004;268:199–205.

    PubMed  Google Scholar 

  110. Reboli AC, Farrar WE. The genus Erysipelothrix. In: Balows A, Truper HG, Dworkin M, Harder W, Schleifer K, editors. The Prokaryotes. A handbook on the biology of bacteria: ecophysiology, isolation, identification, applications. New York: Springer; 1992. p. 1629–42.

    Google Scholar 

Download references

Disclosure

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

  1. Infectious Diseases Unit, Rambam Healthcare Campus, 31096, Haifa, Israel

    Renato Finkelstein & Ilana Oren

  2. The Bruce Rapport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel

    Renato Finkelstein & Ilana Oren

Authors
  1. Renato Finkelstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ilana Oren
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Renato Finkelstein.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Finkelstein, R., Oren, I. Soft Tissue Infections Caused by Marine Bacterial Pathogens: Epidemiology, Diagnosis, and Management. Curr Infect Dis Rep 13, 470–477 (2011). https://doi.org/10.1007/s11908-011-0199-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11908-011-0199-3

Keywords

Search

Navigation